NEVIRA nevirapine 200 mg tablets blister pack

Active ingredient:

nevirapine, Quantity: 200 mg

Available from:

Sun Pharma ANZ Pty Ltd

INN (International Name):

Nevirapine

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type A

Administration route:

Oral

Units in package:

14, 60, 100

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Nevirapine in combination with antiretroviral agents is indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when Nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Product summary:

Visual Identification: White to off-white, oval-shaped, uncoated tablets with a break line on both sides and debossed with 'RX921' on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-11-07